Hospital groups have blocked a contentious new drug-funding model they claimed would cost millions of dollars in lost discounts and have a detrimental effect on care for low-income and rural patients.
On December 29, 2025, the US District Court for the District of Maine issued a preliminary injunction blocking the US Department